Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Asthma · Type 2 Diabetes

AstraZeneca

AstraZeneca clinical programs — 129 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridgeshire CB2 0AA, GB HQ
79,242 Employees
NMPA registrant Type
Company details
Status
Public
HQ
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridgeshire CB2 0AA, GB
Employees
79,242
Programs
129
Drugs
77
Patents
25
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

AstraZeneca projects

129 ClinicalTrials.gov programs sponsored by AstraZeneca.

AstraZeneca has 129 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

129 programs

Clinical programs

Page 2 of 3

  1. Gemcitabine

    AstraZeneca

    Biliary Tract Cancer

    phase 3 small molecule active

    1 trial

  2. IMFINZI 50 mg/mL concentrate for solution for infusion.

    AstraZeneca

    small cell lung cancer

    phase 3 small molecule active

    1 trial

  3. MEDI4736

    AstraZeneca

    Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  4. MEDI4736

    AstraZeneca

    Squamous Cell Carcinoma of the Head and Neck

    phase 3 mab completed

    1 trial

  5. MEDI4736 (Durvalumab)

    AstraZeneca

    Non-Small-Cell Lung Carcinoma NSCLC

    phase 3 mab active

    1 trial

  6. Medi-546

    AstraZeneca

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  7. Metformin

    AstraZeneca

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial

  8. NKTR-118

    AstraZeneca

    Opioid-Induced Constipation

    phase 3 small molecule terminated

    1 trial

  9. NXY-059

    AstraZeneca

    Cerebral Stroke

    phase 3 small molecule completed

    1 trial

  10. OLAPARIB

    AstraZeneca

    Platinum Sensitive Relapsed Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  11. Olaparib

    AstraZeneca

    Breast Cancer Metastatic

    phase 3 small molecule completed

    1 trial

  12. Olaparib 300mg tablets

    AstraZeneca

    Relapsed Ovarian Cancer

    phase 3 small molecule completed

    1 trial

  13. Olaparib 300mg tablets

    AstraZeneca

    Newly Diagnosed

    phase 3 small molecule active

    1 trial

  14. Osimertinib

    AstraZeneca

    Cancer

    phase 3 small molecule active

    1 trial

  15. Placebo

    AstraZeneca

    Irritable Bowel Syndrome With Constipation (IBS-C)

    phase 3 small molecule completed

    1 trial

  16. Puxitatug Samrotecan

    AstraZeneca

    Endometrial Cancer

    phase 3 small molecule active

    1 trial

  17. Quetiapine SR

    AstraZeneca

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  18. Rilvegostomig

    AstraZeneca

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  19. Roflumilast

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  20. Roflumilast

    AstraZeneca

    COPD

    phase 3 small molecule completed

    1 trial

  21. Rosuvastatin 20mg

    AstraZeneca

    Homozygous Familial Hypercholesterolemia (HoFH)

    phase 3 small molecule completed

    1 trial

  22. Roxadustat

    AstraZeneca

    Anemia

    phase 3 small molecule completed

    1 trial

  23. Savolitinib

    AstraZeneca

    Carcinoma

    phase 3 small molecule active

    1 trial

  24. Saxagliptin

    AstraZeneca

    Diabetes

    phase 3 small molecule completed

    1 trial

  25. Seroquel Sustained Release (SR)

    AstraZeneca

    Schizophrenic Disorder

    phase 3 small molecule completed

    1 trial

  26. Sodium Zirconium Cyclosilicate (SZC)

    AstraZeneca

    Hyperkalemia

    phase 3 small molecule terminated

    1 trial

  27. Surovatamig

    AstraZeneca

    Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

    phase 3 small molecule active

    1 trial

  28. Symbicort Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  29. Tesaglitazar

    AstraZeneca

    Type 2 Diabetes

    phase 3 small molecule terminated

    1 trial

  30. Tesaglitazar 0.5 or 1 mg

    AstraZeneca

    Type 2 Diabetes

    phase 3 small molecule terminated

    1 trial

  31. Tezepelumab

    AstraZeneca

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 3 mab active

    2 trials

  32. Tezepelumab

    AstraZeneca

    Asthma

    phase 3 mab active

    2 trials

  33. Ticagrelor

    AstraZeneca

    Acute Coronary Syndrome

    phase 3 small molecule completed

    1 trial

  34. Ticagrelor 90 mg

    AstraZeneca

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  35. Tozorakimab

    AstraZeneca

    Viral Lung Infection and Acute Respiratory Failure

    phase 3 small molecule active

    1 trial

  36. Tozorakimab 1

    AstraZeneca

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 3 other active

    1 trial

  37. Trastuzumab Deruxtecan

    AstraZeneca

    Breast Neoplasms

    phase 3 small molecule active

    1 trial

  38. Trastuzumab Deruxtecan

    AstraZeneca

    Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  39. Trastuzumab deruxtecan

    AstraZeneca

    Breast Cancer; HER2-positive; Metastatic

    phase 3 small molecule active

    1 trial

  40. Trastuzumab deruxtecan

    AstraZeneca

    Advanced or Metastatic Breast Cancer

    phase 3 small molecule active

    1 trial

  41. Tremelimumab

    AstraZeneca

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  42. budesonide/formoterol 'as needed' + budesonide placebo bid

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  43. exenatide once weekly

    AstraZeneca

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  44. volrustomig

    AstraZeneca

    Locally Advanced Head and Neck Squamous Cell Carcinoma

    phase 3 small molecule active

    1 trial

  45. AZD0292

    AstraZeneca

    Bronchiectasis With Pseudomonas Aeruginosa Colonization

    phase 2 mab active

    1 trial

  46. AZD2265 (FPI-2265)

    AstraZeneca

    Metastatic Prostate Cancer

    phase 2 small molecule active

    1 trial

  47. AZD2281

    AstraZeneca

    Ovarian Neoplasms

    phase 2 small molecule completed

    1 trial

  48. AZD5363 when combined with weekly paclitaxel.

    AstraZeneca

    Advanced or Metastatic Breast Cancer

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does AstraZeneca have?

129 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.